Literature DB >> 20139980

Identification of DOK genes as lung tumor suppressors.

Alice H Berger1, Masaru Niki, Alessandro Morotti, Barry S Taylor, Nicholas D Socci, Agnes Viale, Cameron Brennan, Janos Szoke, Noriko Motoi, Paul B Rothman, Julie Teruya-Feldstein, William L Gerald, Marc Ladanyi, Pier Paolo Pandolfi.   

Abstract

Genome-wide analyses of human lung adenocarcinoma have identified regions of consistent copy-number gain or loss, but in many cases the oncogenes and tumor suppressors presumed to reside in these loci remain to be determined. Here we identify the downstream of tyrosine kinase (Dok) family members Dok1, Dok2 and Dok3 as lung tumor suppressors. Single, double or triple compound loss of these genes in mice results in lung cancer, with penetrance and latency dependent on the number of lost Dok alleles. Cancer development is preceded by an aberrant expansion and signaling profile of alveolar type II cells and bronchioalveolar stem cells. In human lung adenocarcinoma, we identify DOK2 as a target of copy-number loss and mRNA downregulation and find that DOK2 suppresses lung cancer cell proliferation in vitro and in vivo. Given the genomic localization of DOK2, we propose it as an 8p21.3 haploinsufficient human lung tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20139980      PMCID: PMC2956443          DOI: 10.1038/ng.527

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  41 in total

1.  ONCOMINE: a cancer microarray database and integrated data-mining platform.

Authors:  Daniel R Rhodes; Jianjun Yu; K Shanker; Nandan Deshpande; Radhika Varambally; Debashis Ghosh; Terrence Barrette; Akhilesh Pandey; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

2.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

3.  Characterization of a novel member of the DOK family that binds and modulates Abl signaling.

Authors:  F Cong; B Yuan; S P Goff
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

4.  p56(dok-2) as a cytokine-inducible inhibitor of cell proliferation and signal transduction.

Authors:  S Suzu; M Tanaka-Douzono; K Nomaguchi; M Yamada; H Hayasawa; F Kimura; K Motoyoshi
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

Review 5.  Self-renewal and solid tumor stem cells.

Authors:  Muhammad Al-Hajj; Michael F Clarke
Journal:  Oncogene       Date:  2004-09-20       Impact factor: 9.867

6.  Dok-6, a Novel p62 Dok family member, promotes Ret-mediated neurite outgrowth.

Authors:  Robert J Crowder; Hideki Enomoto; Mao Yang; Eugene M Johnson; Jeffrey Milbrandt
Journal:  J Biol Chem       Date:  2004-07-30       Impact factor: 5.157

Review 7.  Thyroid transcription factor-1: a review.

Authors:  Sean K Lau; Daniel J Luthringer; Richard N Eisen
Journal:  Appl Immunohistochem Mol Morphol       Date:  2002-06

8.  p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl).

Authors:  A Di Cristofano; M Niki; M Zhao; F G Karnell; B Clarkson; W S Pear; L Van Aelst; P P Pandolfi
Journal:  J Exp Med       Date:  2001-08-06       Impact factor: 14.307

9.  Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation.

Authors:  J Grimm; M Sachs; S Britsch; S Di Cesare; T Schwarz-Romond; K Alitalo; W Birchmeier
Journal:  J Cell Biol       Date:  2001-07-23       Impact factor: 10.539

10.  An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors.

Authors:  D Chitale; Y Gong; B S Taylor; S Broderick; C Brennan; R Somwar; B Golas; L Wang; N Motoi; J Szoke; J M Reinersman; J Major; C Sander; V E Seshan; M F Zakowski; V Rusch; W Pao; W Gerald; M Ladanyi
Journal:  Oncogene       Date:  2009-06-15       Impact factor: 9.867

View more
  55 in total

1.  Oncogenic tyrosine kinases target Dok-1 for ubiquitin-mediated proteasomal degradation to promote cell transformation.

Authors:  Justyna A Janas; Linda Van Aelst
Journal:  Mol Cell Biol       Date:  2011-05-02       Impact factor: 4.272

2.  Update in lung cancer and oncological disorders 2010.

Authors:  Balazs Halmos; Charles A Powell
Journal:  Am J Respir Crit Care Med       Date:  2011-08-01       Impact factor: 21.405

3.  Aid is a key regulator of myeloid/erythroid differentiation and DNA methylation in hematopoietic stem/progenitor cells.

Authors:  Hiroyoshi Kunimoto; Anna Sophia McKenney; Cem Meydan; Kaitlyn Shank; Abbas Nazir; Franck Rapaport; Benjamin Durham; Francine E Garrett-Bakelman; Elodie Pronier; Alan H Shih; Ari Melnick; Jayanta Chaudhuri; Ross L Levine
Journal:  Blood       Date:  2017-01-11       Impact factor: 22.113

4.  Mutational analysis of the DOK2 haploinsufficient tumor suppressor gene in chronic myelomonocytic leukemia (CMML).

Authors:  E Coppin; V Gelsi-Boyer; X Morelli; N Cervera; A Murati; P P Pandolfi; D Birnbaum; J A Nunès
Journal:  Leukemia       Date:  2014-09-25       Impact factor: 11.528

5.  Region-Specific Dok2 Overexpression Associates with Poor Prognosis in Human Astrocytoma.

Authors:  Ravindra Pramod Deshpande; Y B V K Chandra Sekhar; Manas Panigrahi; Phanithi Prakash Babu
Journal:  Mol Neurobiol       Date:  2016-12-14       Impact factor: 5.590

6.  Intratumoral Heterogeneity of Somatic Mutations for NRIP1, DOK1, ULK1, ULK2, DLGAP3, PARD3 and PRKCI in Colon Cancers.

Authors:  Eun Ji Choi; Ju Hwa Lee; Min Sung Kim; Sang Yong Song; Nam Jin Yoo; Sug Hyung Lee
Journal:  Pathol Oncol Res       Date:  2017-08-26       Impact factor: 3.201

7.  Transcriptional regulation of the human tumor suppressor DOK1 by E2F1.

Authors:  Maha Siouda; Jiping Yue; Ruchi Shukla; Sophie Guillermier; Zdenko Herceg; Marion Creveaux; Rosita Accardi; Massimo Tommasino; Bakary S Sylla
Journal:  Mol Cell Biol       Date:  2012-10-01       Impact factor: 4.272

8.  Docking protein-1 promotes inflammatory macrophage signaling in gastric cancer.

Authors:  Tong Li; Beifang Li; Asgharpour Sara; Christine Ay; Wing Yan Leung; Yanquan Zhang; Yujuan Dong; Qiaoyi Liang; Xiang Zhang; Philip Weidner; Tobias Gutting; Hans-Michael Behrens; Christoph Röcken; Joseph Jy Sung; Matthias P Ebert; Jun Yu; Elke Burgermeister
Journal:  Oncoimmunology       Date:  2019-08-21       Impact factor: 8.110

9.  The Dok-3/Grb2 protein signal module attenuates Lyn kinase-dependent activation of Syk kinase in B cell antigen receptor microclusters.

Authors:  Marion Lösing; Ingo Goldbeck; Birgit Manno; Thomas Oellerich; Tim Schnyder; Hanibal Bohnenberger; Björn Stork; Henning Urlaub; Facundo D Batista; Jürgen Wienands; Michael Engelke
Journal:  J Biol Chem       Date:  2012-12-05       Impact factor: 5.157

10.  A physical interaction between the adaptor proteins DOK3 and DAP12 is required to inhibit lipopolysaccharide signaling in macrophages.

Authors:  Qisheng Peng; Courtney L Long; Shikha Malhotra; Mary Beth Humphrey
Journal:  Sci Signal       Date:  2013-08-20       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.